StockSelector.com
  Research, Select, & Monitor Sunday, July 15, 2018 7:25:39 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ionis Pharmaceuticals, Inc.$45.24($.35)(.77%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ionis Pharmaceuticals, Inc. has an overall rank of 1906 out of 7006 stocks based on 8 positive rankings and 11 negative rankings.

Positive Rankings
Estimated EPS Growth
Ionis Pharmaceuticals rank is 45
Up EPS Surprise
Ionis Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Historic Revenue Growth
Ionis Pharmaceuticals rank is 310
SSValue
The StockSelector Value for Ionis Pharmaceuticals is $128.70. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ionis Pharmaceuticals is ranked 328.
PEGValue
Ionis Pharmaceuticals has a PEG Value of $61.26. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 35.40% in the next year. Among companies with a PEG Value above the current stock price, Ionis Pharmaceuticals is ranked 426.
Estimated Revenue Growth
Ionis Pharmaceuticals rank is 426
10 Day Gain
Ionis Pharmaceuticals rank is 585
Low Put/Call
Ionis Pharmaceuticals has a low Put/Call ratio of 0.48 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Ionis Pharmaceuticals is ranked 933.
Negative Rankings
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Ionis Pharmaceuticals is ranked 141.
Price-to-Book
Ionis Pharmaceuticals rank is 308
Price-to-Sales
Ionis Pharmaceuticals rank is 513
Overbought Stochastics
Ionis Pharmaceuticals rank is 1072
90 Day Loss
Ionis Pharmaceuticals rank is 1110
High vPut/Call
Ionis Pharmaceuticals has a high Put/Call ratio of 0.48 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ionis Pharmaceuticals is ranked 1136.
Negative Net Margin
Ionis Pharmaceuticals rank is 1298
Negative ROE
Ionis Pharmaceuticals rank is 1487
Debt-to-Equity
Ionis Pharmaceuticals rank is 1527
Negative Cash Growth
Ionis Pharmaceuticals rank is 1627
Negative ROA
Ionis Pharmaceuticals rank is 1783







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.